Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8951–9000 of 18658
on August 8, 2023, the Board of Directors (the “ Board ”) of the Company approved the appointment of Robert C. Daigle to succeed Michael Whang as President and Chief Executive Officer of the Company effective August 8, 2023.
on August 8, 2023, the Board of Directors (the “ Board ”) of the Company approved the appointment of Robert C. Daigle to succeed Michael Whang as President and Chief Executive Officer of the Company effective August 8, 2023.
Dean A. Shigenaga, President and Chief Financial Officer of Alexandria Real Estate Equities, Inc. (the “Company”), submitted his resignation from all of his positions with the Company and its subsidiaries for important personal family health reasons, effective September 15, 2023.
the Board elected Marc E. Binda as Chief Financial Officer and Treasurer, effective September 15, 2023.
Yasir Al-Wakeel, BM BCh, the Chief Financial Officer and Head of Corporate Development, principal financial officer and principal accounting officer of Kronos Bio, Inc. (the "Company"), notified the Company of his decision to resign, effective at the close of business on September 15, 2023, to pursue other opportunities.
Josh Blacher of Danforth, an experienced biotech executive who specializes in strategic finance and corporate development, has been named as the Company’s Interim Chief Financial Officer.
Bob Myers, the Chief Financial Officer, Corporate Secretary and Compliance Officer of Predictive Oncology Inc. (the "Company"), notified the Company of his intent to resign from the Company effective September 30, 2023 (the "Transition Date").
On August 11, 2023, Joe Annoni, Chief Financial Officer and Assistant Chief Restructuring Officer of Athenex, Inc. (the “Company”), and the Company mutually agreed that Mr. Annoni would separate from the Company effective immediately.
John Alam, MD has served as the President and Chief Executive Officer of the Company since August 2023.
William Tanner, Ph.D has served as the Company’s Chief Financial Officer since August 2023.
On August 14, 2023, the Company appointed Gerbrand van Heerden as the Chief Financial Officer of the Company, effective as of October 14, 2023.
On August 13, 2023, David Wiens resigned as the Chief Financial Officer of Bunker Hill Mining Corp. (the “ Company ”), effective as of October 14, 2023.
On August 16, 2023 (the “Transition Date”), Perry Del Vecchio resigned as the Chief Financial Officer of Alico, Inc. (the “Company”), effective immediately.
On the Transition Date, in connection with Mr. Del Vecchio’s resignation, the Company’s Board of Directors appointed Bradley Heine as the Company’s new Chief Financial Officer, effective immediately.
appointed Leonardo Basola as the Company’s Chief Financial Officer, effective September 5, 2023
who is resigning as Chief Financial Officer as previously disclosed
Also on August 15, 2023, the Company and John Taylor, the Company’s President, Chief Executive Officer, Chief Financial Officer and member of the Board, entered into that certain Executive Separation Agreement (the “Separation Agreement”), pursuant to which, in connection and contemporaneous with the Company’s entry into the Assignment Agreement and effectuation of the Assignment pursuant thereto, Mr. Taylor’s employment with the Company terminated.
the Board promoted Sassine Ghazi, Synopsys’ President and Chief Operating Officer, to the role of President and Chief Executive Officer
Tim Foufas, a long-time Board member, was appointed as Co-CEO and will serve as the Company's Principal Executive Officer, replacing Michael Ferrantino.
as Michael Ferrantino transitions from management to the Board.
On August 3, 2023, the Company and Jupiter Wellness entered into an Assignment and Assumption Agreement (the “McKinnon Assignment”), which became effective on August 14, 2023, to assume the employment agreement dated August 5, 2019, between Douglas McKinnon, Chief Financial Officer of the Company and former Chief Financial Officer of Jupiter Wellness, and Jupiter Wellness.
On August 15, 2023, TrueBlue, Inc. (the “Company”) announced that its current President and Chief Operating Officer, Taryn R. Owen, will become President and Chief Executive Officer of the Company, succeeding Steven C. Cooper, effective September 12, 2023.
On August 15, 2023, TrueBlue, Inc. (the “Company”) announced that its current President and Chief Operating Officer, Taryn R. Owen, will become President and Chief Executive Officer of the Company, succeeding Steven C. Cooper, effective September 12, 2023.
appointed Kenneth J. Zagzebski as Chairman of the Board and President and Chief Executive Officer of IPALCO and AES Indiana.
Effective September 30, 2023, Antonio Martino, Chief Financial Officer of the Company and the Bank, will depart from his role as Chief Financial Officer.
Effective August 15, 2023, each of Alan J. Lane, President and Chief Executive Officer of the Company and Chief Executive Officer of the Bank, and John M. Bonino, Chief Legal Officer of the Company and the Bank, will depart from their respective positions.
On August 15, 2023, the Company announced that William L. Ballhaus has been appointed as the Company’s President and Chief Executive Officer.
On August 15, 2023, the Company’s Board of Directors appointed Shankar Musunuri, Ph.D., MBA, the Company’s Chairman, Chief Executive Officer & Co-Founder, as the interim principal financial officer, effective immediately, in light of Mr. Vu’s departure.
Effective August 14, 2023, Quan Vu is no longer serving as the Chief Financial Officer/Chief Business Officer, and as principal financial officer and principal accounting officer, of Ocugen, Inc.
appointed James Britton as Executive Vice President and Chief Financial Officer, effective as of August 14, 2023.
Randolph W. Hubbell 60 Chief Executive Officer, President and Director
Bryan Cassaday 55 Interim Chief Financial Officer
Effective August 15, 2023, John Givens will assume the role of the Company’s Chief Executive Officer (CEO).
appointed Randell Weaver to be the Company’s new Chief Financial Officer, effective immediately.
Effective on August 14, 2023, Troika Media Group, Inc. (the “Company”) terminated the employment of Sadiq Toama, its Chief Executive Officer, for “Cause,” pursuant to the terms of his employment agreement.
and Eric Glover as the Company’s Interim Chief Financial Officer.
The Company has also terminated the employment of Erica Naidrich, its Chief Financial Officer, for “Cause,” pursuant to the terms of her employment agreement.
Effective immediately, the Company has appointed Grant Lyon, a current member of the Board, as the Company’s Interim Chief Executive Officer
On August 11, 2023, the Boards of Directors of Carver Bancorp, Inc. (the “Company”) and Carver Federal Savings Bank (the “Bank”) each unanimously appointed Craig C. MacKay as Interim President and Chief Executive Officer, effective October 1, 2023.
The Company previously announced that its current President and Chief Executive Officer, Michael T. Pugh, will depart on September 30, 2023, to become the Chief Executive Officer of the Local Initiatives Support Coalition, a national nonprofit organization.
On August 14, 2023, the Board of Directors of the Company (the “Board”), appointed Florence Neubauer, 51, the Company’s Senior Vice President, Financial Planning & Analysis (“FP&A”), to serve as the Company’s Interim Chief Financial Officer.
On August 10, 2023, Denise D. Beckles, the Company’s Chief Financial Officer, notified the Company of her resignation, effective September 4, 2023 to pursue another opportunity.
On August 14, 2023, the Company announced the appointment of Gülsen Kama as Bionano Genomics, Inc.’s (the “Company”) Chief Financial Officer, effective as of September 11, 2023
On August 11, 2023, Christopher Stewart resigned as Chief Financial Officer of the Company effective as of September 11, 2023
and as Chief Executive Officer and a member of the Board of Kraft Heinz, effective January 1, 2024
appointed Alex Chriss as President and Chief Executive Officer of the Company (“CEO”), effective as of September 27, 2023
On August 8, 2023, Dean Kaye, the Chief Financial Officer - North America, and principal accounting officer of Advantage Solutions Inc. (the “Company”), has notified the Company as to his intent to resign from his positions with the Company effective as of February 1, 2024.
the Board appointed John B. Owen as Interim Chief Executive Officer and Interim President of the Company and as Interim President of the Bank, effective August 14, 2023
On August 10, 2023, the Board resolved to appoint Ms. Caihong Qu as a member of the Board and the interim Chief Executive Officer and Chief Financial Officer of the Company, until the next annual meeting of the Corporation’s shareholders, and until her successor is elected and qualified or until her prior disqualification.
Ms. Qu is the late wife of Mr. Xianchang Ma, our previous Director, CEO and CFO, who passed away on August 3, 2023.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.